Remove world asia
article thumbnail

WHO’s top scientist learned a hard lesson about H5N1 two decades ago: Stopping it takes more than biology

STAT

Jeremy Farrar, now the World Health Organization’s chief scientist, was working in Vietnam 20 years ago when the H5N1 virus started to spread across Asia — at that point in poultry. He recalls there was a reluctance among farmers to cull their chickens because they weren’t being compensated for them.

354
354
article thumbnail

3rd World ADC Asia

pharmaphorum

Optimising Physiochemical, Potency & Impurity Analytical Methods to Ensure Regulatory Compliance

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific

Pharma Mirror

New Delhi, India, More than 50 per cent of the world’s hip fractures are expected to occur in the Asia Pacific by the year 2050. The post Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific appeared first on Pharma Mirror Magazine.

52
article thumbnail

STAT+: Even with gene therapy on the horizon, drugmakers join hunt for new sickle cell drugs

STAT

  And they require too much medical infrastructure to be given in most of South Asia and West Africa, where most of the world’s roughly 120 million sickle cell patients live. and Europe.  Continue to STAT+ to read the full story…

241
241
article thumbnail

DKSH Performance Materials acquires Elite Organic in Malaysia

Express Pharma

Elite Organic represents world-renowned manufacturers from Europe, the US, Japan, and Asia. This acquisition is a unique opportunity for DKSH to further expand our highly attractive life science business in Asia Pacific. Elite Organic generates net sales of over CHF 5 million¹ at sound profitability and return on capital.

97
article thumbnail

STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys

STAT

… Chinese pharmaceutical companies are developing domestic versions of “miracle” weight-loss drugs as they take on Western drugmakers selling anti-obesity medication in one of the world’s biggest markets , The Financial Times tells us. And the SEC wants to know whether Inotiv complied with the U.S.

article thumbnail

AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023

Express Pharma

AstraZeneca presented new data findings from Phase-III studies of HIMALAYA and MATTERHORN a t the ESMO Asia Congress 2023, The company showcased innovative therapeutic options, particularly in the efficacy of immunotherapy combinations in treating advanced unresectable hepatocellular carcinoma and early gastric cancer.

Immunity 103